-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CSWQNKeVxkhTNoqAObj/0/yp9F3FiJOic2WHDagxMeECf8uxkmU6mhs4nDMVo5wp FjFhmaogCMDQjfcThwVxiw== 0000903893-97-000382.txt : 19970228 0000903893-97-000382.hdr.sgml : 19970228 ACCESSION NUMBER: 0000903893-97-000382 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970227 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON BIOMEDICA INC CENTRAL INDEX KEY: 0000830656 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042652826 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-50285 FILM NUMBER: 97545105 BUSINESS ADDRESS: STREET 1: 375 WEST STREET CITY: WEST BRIDGEWATER STATE: MA ZIP: 02379 BUSINESS PHONE: 5085801900 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MALKASIAN HENRY A CENTRAL INDEX KEY: 0001034250 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 119 BRISTOL ROAD CITY: WELLESLEY STATE: MA ZIP: 02181 MAIL ADDRESS: STREET 1: 119 BRISTOL ROAD CITY: WELLESLEY STATE: MA ZIP: 02181 SC 13G 1 SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.____________)* BOSTON BIOMEDICA, INC. ----------------------------------------------------- (Name of Issuer) Common Stock, $.01 par value ----------------------------------------------------- (Title of Class of Securities) 100560101 ----------------------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 100560101 13G Page 1 of 5 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS Henry A. Malkasian - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION USA - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 311,510 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH -0- REPORTING -------------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 311,510 -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER -0- - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 311,510 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [X] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.1% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- Page 2 of 5 Pages Item 1. (a) Name of Issuer: Boston Biomedica, Inc. (b) Address of Issuer's Principal Executive Offices: 375 West Street, West Bridgewater, Massachusetts 02379 Item 2. (a) Name of Person Filing: Henry A. Malkasian (b) Address of Principal Business Office, or, if none, Residence: 119 Bristol Road, Wellesley, Massachusetts 02181 (c) Citizenship: USA (d) Title of Class of Securities: Common Stock, $.01 par value (e) CUSIP Number: 100560101 Item 3. Not Applicable Item 4. Ownership: (a) Amount Beneficially Owned: 311,510 shares, including (i) 10,000 shares issuable pursuant to immediately exercisable stock options, (ii) 12,000 shares held of record by Mr. Malkasian's son, (iii) 5,000 shares held by Mr. Malkasian's daughter, (iv) 53,850 shares held by Mr. Malkasian's spouse, (v) 30,000 shares Page 3 of 5 Pages held by Mr. Malkasian as trustee in trust for his son, and (vi) 30,000 shares held by Mr. Malkasian as trustee for his daughter. (b) Percent of Class: 7.1% (c) Number of Shares as to which such person has: (i) sole power to vote or to direct the vote: 311,510 shares (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: 311,510 shares (iv) shared power to dispose or to direct the disposition of: -0- Item 5. Ownership of Five Percent or Less of Class: Not Applicable Item 6. Ownership of More Than Five Percent on Behalf of Another Person: Not Applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company: Not Applicable Item 8. Identification and Classification of Members of the Group: Not Applicable Item 9. Notice of Dissolution of Group: Not Applicable Item 10. Certification: Not Applicable Page 4 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: 2/21/97 ------- By: /s/ Henry A. Malkasian ---------------------- Henry A. Malkasian Page 5 of 5 Pages -----END PRIVACY-ENHANCED MESSAGE-----